东诚药业
(002675)
| 流通市值：110.62亿 | | | 总市值：122.70亿 |
| 流通股本：7.43亿 | | | 总股本：8.25亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,045,039,473.98 | 742,711,892.77 | 697,376,537.69 | 755,972,381.28 |
| 交易性金融资产 | 114,074,931.5 | 200,693,682.19 | 140,796,383.56 | 148,541,546.31 |
| 应收票据及应收账款 | 970,895,908.39 | 961,326,165.79 | 942,784,583.2 | 927,454,486.75 |
| 其中：应收票据 | 9,513,231.26 | 10,118,037.63 | 12,482,457.24 | 15,041,474.93 |
| 应收账款 | 961,382,677.13 | 951,208,128.16 | 930,302,125.96 | 912,413,011.82 |
| 应收款项融资 | 16,453,723.14 | 14,849,509.05 | 13,061,988.13 | 8,782,652.11 |
| 预付款项 | 33,001,090.37 | 31,773,013.4 | 26,994,547.11 | 27,160,841.34 |
| 其他应收款合计 | 22,072,423.84 | 16,311,087.18 | 14,079,067.17 | 12,486,659.78 |
| 应收股利 | - | - | 1,097,550 | - |
| 存货 | 630,481,842.11 | 629,388,760.94 | 605,047,336.63 | 646,221,273.48 |
| 一年内到期的非流动资产 | 3,031,216.45 | 3,974,068.88 | 3,397,370.32 | 3,374,653.98 |
| 其他流动资产 | 43,827,668.06 | 46,330,721.7 | 30,991,885.5 | 37,654,028.35 |
| 流动资产合计 | 2,878,878,277.84 | 2,647,358,901.9 | 2,474,529,699.31 | 2,567,648,523.38 |
| 非流动资产: | | | | |
| 债权投资 | 40,254,398.84 | 39,838,186.63 | 39,229,835.5 | 38,568,709.29 |
| 长期应收款 | - | - | 1,520,945.92 | 1,520,945.92 |
| 长期股权投资 | 245,099,019.27 | 200,531,006.51 | 207,435,530.34 | 211,285,607.8 |
| 其他权益工具投资 | 106,200,000 | 106,200,000 | 106,200,000 | 106,200,000 |
| 投资性房地产 | 19,800,829.57 | 19,924,198.06 | 20,047,566.55 | 19,831,354.59 |
| 固定资产 | 1,762,020,600.35 | 1,694,756,057.2 | 1,712,063,403.46 | 1,730,899,116.52 |
| 在建工程 | 612,711,127.33 | 653,357,191.73 | 589,012,623.86 | 567,907,007.76 |
| 使用权资产 | 162,025,209.32 | 143,137,298.87 | 126,005,629.92 | 36,091,555.28 |
| 无形资产 | 285,416,337.86 | 289,841,467.28 | 247,132,338.94 | 252,539,244.52 |
| 开发支出 | 271,113,043.98 | 256,284,309.78 | 279,610,812.24 | 265,690,610.52 |
| 商誉 | 2,495,702,954.82 | 2,498,974,062.01 | 2,500,181,476.34 | 2,500,809,824.61 |
| 长期待摊费用 | 152,065,083.15 | 152,961,418.47 | 146,144,502.37 | 97,332,150.33 |
| 递延所得税资产 | 111,206,346.85 | 108,585,832.08 | 99,917,289.16 | 94,889,299.71 |
| 其他非流动资产 | 142,863,664.09 | 143,763,919.01 | 137,947,936.49 | 143,464,046.21 |
| 非流动资产合计 | 6,406,478,615.43 | 6,308,154,947.63 | 6,212,449,891.09 | 6,067,029,473.06 |
| 资产总计 | 9,285,356,893.27 | 8,955,513,849.53 | 8,686,979,590.4 | 8,634,677,996.44 |
| 流动负债: | | | | |
| 短期借款 | 336,452,353.61 | 313,301,157.77 | 288,123,011.43 | 448,879,586.83 |
| 应付票据及应付账款 | 578,847,730.02 | 621,726,216.39 | 595,358,686.43 | 588,406,696.41 |
| 其中：应付票据 | 372,679,535.24 | 396,525,965.44 | 389,243,191.89 | 393,667,747.52 |
| 应付账款 | 206,168,194.78 | 225,200,250.95 | 206,115,494.54 | 194,738,948.89 |
| 预收款项 | 161,222.43 | 204,260.72 | 243,882.87 | 376,957.75 |
| 合同负债 | 131,325,183.9 | 140,642,600.57 | 103,262,680.75 | 105,632,249.25 |
| 应付职工薪酬 | 105,213,188.14 | 96,686,183.41 | 88,442,409.66 | 116,490,184.61 |
| 应交税费 | 105,677,135.62 | 90,451,006.09 | 78,638,587.19 | 70,018,035.62 |
| 其他应付款合计 | 350,119,818.57 | 264,526,999.83 | 298,686,458.76 | 330,347,243.92 |
| 其中:应付利息 | 4,777,532.79 | 4,709,146.04 | 4,963,516.52 | 5,160,165.99 |
| 应付股利 | 38,196,306.4 | 21,818,781.73 | 37,727,605.71 | 53,580,427.68 |
| 一年内到期的非流动负债 | 68,535,920.44 | 67,903,891.16 | 75,078,603.16 | 73,987,713.73 |
| 其他流动负债 | 10,141,623.11 | 11,632,110.51 | 14,513,907.83 | 19,817,452.6 |
| 流动负债合计 | 1,686,474,175.84 | 1,607,074,426.45 | 1,542,348,228.08 | 1,753,956,120.72 |
| 非流动负债: | | | | |
| 长期借款 | 347,811,232.45 | 319,282,889.81 | 317,138,046.69 | 301,857,994.42 |
| 租赁负债 | 157,135,164.48 | 133,446,548.29 | 122,183,457.94 | 33,882,639.01 |
| 长期应付款 | 1,437,441,306.51 | 1,223,900,137.45 | 1,094,021,310.94 | 958,202,692.18 |
| 预计负债 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 |
| 递延收益 | 193,228,657.78 | 197,390,489.35 | 192,374,440.1 | 195,685,123.73 |
| 递延所得税负债 | 15,616,373.69 | 16,830,252.57 | 16,813,302.03 | 17,405,583.24 |
| 非流动负债合计 | 2,153,452,623.16 | 1,893,070,205.72 | 1,744,750,445.95 | 1,509,253,920.83 |
| 负债合计 | 3,839,926,799 | 3,500,144,632.17 | 3,287,098,674.03 | 3,263,210,041.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 824,595,705 | 824,595,705 | 824,595,705 | 824,595,705 |
| 资本公积 | 1,770,909,455.57 | 1,941,854,490.63 | 1,988,379,422.19 | 1,998,256,195.26 |
| 其他综合收益 | 10,525,795.09 | 14,513,619.44 | 14,966,678.77 | 14,841,578.28 |
| 盈余公积 | 279,244,326.85 | 279,244,326.85 | 279,244,326.85 | 279,244,326.85 |
| 未分配利润 | 1,487,884,878.66 | 1,427,421,428.66 | 1,388,238,365.73 | 1,363,506,842.54 |
| 归属于母公司股东权益合计 | 4,373,160,161.17 | 4,487,629,570.58 | 4,495,424,498.54 | 4,480,444,647.93 |
| 少数股东权益 | 1,072,269,933.1 | 967,739,646.78 | 904,456,417.83 | 891,023,306.96 |
| 股东权益合计 | 5,445,430,094.27 | 5,455,369,217.36 | 5,399,880,916.37 | 5,371,467,954.89 |
| 负债和股东权益合计 | 9,285,356,893.27 | 8,955,513,849.53 | 8,686,979,590.4 | 8,634,677,996.44 |
| 公告日期 | 2025-10-29 | 2025-08-15 | 2025-04-30 | 2025-02-27 |
| 审计意见(境内) | | | | 标准无保留意见 |